Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 3Head & Neck 2Genitourinary 2Dermatologic 2Thoracic 1Sarcoma 1Other solid neoplasm 1Endocrine 1CNS 1

Conditions

Mesothelioma 13Mesothelioma, Malignant 7Carcinoma, Non-Small-Cell Lung 5Solid Tumor 4Ovarian Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumor, Adult 2Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Lung Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Turcot syndrome 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Microsatellite Unstable Colorectal Cancer 1Metastatic Solid Tumors 1Liver Neoplasms 1Kidney Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1

Interventions

pembrolizumab 5spartalizumab 2fludarabine 2budigalimab 2Nivolumab 2Cyclophosphamide 2venetoclax 1tislelizumab 1rovalpituzumab tesirine 1niraparib 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Ipilimumab 1Immunotherapy 1Fluorodeoxyglucose F18 1Drug Therapy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × Ipilimumab × Other solid neoplasm × Clear all
NCT03907852 2025-08-27

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

TCR2 Therapeutics

Phase 1/2 Active not recruiting
57 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡